DBC
ETFInvesco DB Commodity Index Tracking Fund
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$34.2M
Portfolio Weight
8.97%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$380.9M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
DBC
ETFInvesco DB Commodity Index Tracking Fund
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$34.2M
Portfolio Weight
8.97%
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
45.9K
Position Mix
No options reported
Reported Value
$9.4M
Portfolio Weight
2.47%
ABVX
Depositary ReceiptAbivax S.A.
Reported Shares
87.1K
Position Mix
No options reported
Reported Value
$8.6M
Portfolio Weight
2.26%
PCVX
Common StockVaxcyte, Inc.
Reported Shares
142.1K
Position Mix
No options reported
Reported Value
$8.1M
Portfolio Weight
2.12%
GMAB
Depositary ReceiptGENMAB A/S
Reported Shares
226.1K
Position Mix
No options reported
Reported Value
$8.1M
Portfolio Weight
2.12%
RLAY
Common StockRelay Therapeutics, Inc.
Reported Shares
409.3K
Position Mix
No options reported
Reported Value
$7.4M
Portfolio Weight
1.94%
TNGX
Common StockTango Therapeutics, Inc.
Reported Shares
287.8K
Position Mix
No options reported
Reported Value
$7.2M
Portfolio Weight
1.89%
TARS
Common StockTarsus Pharmaceuticals, Inc.
Reported Shares
90.4K
Position Mix
No options reported
Reported Value
$7.1M
Portfolio Weight
1.87%
IMVT
Common StockImmunovant, Inc.
Reported Shares
206K
Position Mix
No options reported
Reported Value
$7.0M
Portfolio Weight
1.83%
COGT
Common StockCogent Biosciences, Inc.
Reported Shares
210.1K
Position Mix
No options reported
Reported Value
$6.7M
Portfolio Weight
1.77%
LBRX
Common StockLB PHARMACEUTICALS INC
Reported Shares
173.8K
Position Mix
No options reported
Reported Value
$6.7M
Portfolio Weight
1.75%
MANE
Common StockVeradermics, Inc
Reported Shares
54.2K
Position Mix
No options reported
Reported Value
$6.6M
Portfolio Weight
1.73%
EWTX
Common StockEdgewise Therapeutics, Inc.
Reported Shares
160.6K
Position Mix
No options reported
Reported Value
$6.5M
Portfolio Weight
1.71%
ALKS
Common StockAlkermes plc.
Reported Shares
156.8K
Position Mix
No options reported
Reported Value
$6.4M
Portfolio Weight
1.67%
CMPS
Depositary ReceiptCOMPASS Pathways plc
Reported Shares
508.8K
Position Mix
No options reported
Reported Value
$6.3M
Portfolio Weight
1.66%
VRDN
Common StockViridian Therapeutics, Inc.\DE
Reported Shares
272.6K
Position Mix
No options reported
Reported Value
$5.6M
Portfolio Weight
1.47%
GPCR
Depositary ReceiptStructure Therapeutics Inc.
Reported Shares
170.2K
Position Mix
No options reported
Reported Value
$5.3M
Portfolio Weight
1.40%
NRIX
Common StockNurix Therapeutics, Inc.
Reported Shares
221K
Position Mix
No options reported
Reported Value
$5.2M
Portfolio Weight
1.38%
NVDA
Common StockNVIDIA CORP
Reported Shares
21.9K
Position Mix
No options reported
Reported Value
$5.0M
Portfolio Weight
1.31%
TYRA
Common StockTyra Biosciences, Inc.
Reported Shares
227.4K
Position Mix
No options reported
Reported Value
$5.0M
Portfolio Weight
1.31%